Nobuyoshi Yamazaki

Fecal miR-106a Is a Useful Marker for Colorectal Cancer Patients with False-Negative Results in Immunochemical Fecal Occult Blood Test

Yoshikatsu Koga, Nobuyoshi Yamazaki, Yoshiyuki Yamamoto et al. · Cancer Epidemiology Biomarkers & Prevention · 2013 · 83 citations

High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer

Nobuyoshi Yamazaki, Yoshikatsu Koga, Hirokazu Taniguchi et al. · Oncotarget · 2016 · 50 citations · Full text

Prognostic Factors Affecting Survival After Multivisceral Resection in Patients with Clinical T4b Gastric Cancer

Kazuhito Mita, Hideto Ito, Toshio Katsube et al. · Journal of Gastrointestinal Surgery · 2017 · 34 citations

Prognostic Factors, Surgical Oncology, Gastrointestinal Oncology +8

High expression of post-treatment Ki-67 status is a risk factor for locoregional recurrence following breast-conserving surgery after neoadjuvant chemotherapy

Nobuyoshi Yamazaki, Noriaki Wada, Chisako Yamauchi et al. · European Journal of Surgical Oncology · 2015 · 22 citations

Surgical Oncology, Breast Oncology, Post-treatment Ki-67 Status +11

Application of the Fecal MicroRNA Test to the Residuum from the Fecal Occult Blood Test

Nobuyoshi Yamazaki, Yoshikatsu Koga, Seiichiro Yamamoto et al. · Japanese Journal of Clinical Oncology · 2013 · 19 citations · Full text